U.S. to buy at least 100,000 doses of Lilly’s COVID-19 antibody therapy
Drugmaker Eli Lilly and Co said on Friday the U.S. government has agreed to buy at least 100,000 doses of its newly authorized COVID-19 dual antibody cocktail for $210 million, with doses to be delivered through March-end.